Identification of diagnostic markers of pancreatic ductal adenocarcinoma using transcriptomic tumour and blood sample data
Abstract Background Pancreatic ductal adenocarcinoma (PDAC) is the most frequently diagnosed form of pancreatic cancer worldwide. PDAC is associated with a poor survival rate mainly due to the disease being usually diagnosed at late stages. Methods Publicly available gene expression data from 10 stu...
Main Authors: | Aristeidis Sionakidis, Panagiotis Nikolaos Lalagkas, Andigoni Malousi, Ioannis S. Vizirianakis |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2023-10-01
|
Series: | Clinical and Translational Discovery |
Subjects: | |
Online Access: | https://doi.org/10.1002/ctd2.248 |
Similar Items
-
Diagnostic and Prognostic Performance of MicroRNA-25, Carbohydrate Antigen 19-9, Carcinoembryonic Antigen, and Carbohydrate Antigen 125 in Pancreatic Ductal Adenocarcinoma
by: Yan Gong, et al.
Published: (2023-07-01) -
Innate and adaptive immune-directed tumour microenvironment in pancreatic ductal adenocarcinoma
by: Ann Mary Joseph, et al.
Published: (2024-02-01) -
Oral mycobiota and pancreatic ductal adenocarcinoma
by: Ailin Wei, et al.
Published: (2022-12-01) -
Inhibiting CDK4/6 in pancreatic ductal adenocarcinoma via microRNA-21
by: Maria Mortoglou, et al.
Published: (2023-06-01) -
Role of Endoscopic Ultrasound in Diagnosis of Pancreatic Ductal Adenocarcinoma
by: Abhirup Chatterjee, et al.
Published: (2023-12-01)